Gilson P - Search Results

1

DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib.

Dardare J, Witz A, Betz M, François A, Lamy L, Husson M, Demange J, Rouyer M, Lambert A, Merlin JL, Gilson P, Harlé A. Dardare J, et al. Among authors: gilson p. Cell Death Discov. 2024 Sep 27;10(1):411. doi: 10.1038/s41420-024-02188-9. Cell Death Discov. 2024. PMID: 39333096 Free PMC article.

2

Uncommon mutational profiles of metastatic colorectal cancer detected during routine genotyping using next generation sequencing.

Franczak C, Kandathil SM, Gilson P, Husson M, Rouyer M, Demange J, Leroux A, Merlin JL, Harlé A. Franczak C, et al. Among authors: gilson p. Sci Rep. 2019 May 8;9(1):7083. doi: 10.1038/s41598-019-43646-0. Sci Rep. 2019. PMID: 31068650 Free PMC article.

3

Emerging Roles of DDB2 in Cancer.

Gilson P, Drouot G, Witz A, Merlin JL, Becuwe P, Harlé A. Gilson P, et al. Int J Mol Sci. 2019 Oct 18;20(20):5168. doi: 10.3390/ijms20205168. Int J Mol Sci. 2019. PMID: 31635251 Free PMC article. Review.

4

SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma.

Dardare J, Witz A, Merlin JL, Gilson P, Harlé A. Dardare J, et al. Among authors: gilson p. Int J Mol Sci. 2020 May 16;21(10):3534. doi: 10.3390/ijms21103534. Int J Mol Sci. 2020. PMID: 32429474 Free PMC article. Review.

5

Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities.

Dardare J, Witz A, Merlin JL, Bochnakian A, Toussaint P, Gilson P, Harlé A. Dardare J, et al. Among authors: gilson p. Pharmaceuticals (Basel). 2021 Jul 29;14(8):740. doi: 10.3390/ph14080740. Pharmaceuticals (Basel). 2021. PMID: 34451837 Free PMC article. Review.

6

Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy.

Gilson P, Merlin JL, Harlé A. Gilson P, et al. Cancers (Basel). 2022 Mar 8;14(6):1384. doi: 10.3390/cancers14061384. Cancers (Basel). 2022. PMID: 35326534 Free PMC article. Review.

7

DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy.

Dardare J, Witz A, Betz M, Francois A, Meras M, Lamy L, Lambert A, Grandemange S, Husson M, Rouyer M, Demange J, Merlin JL, Harlé A, Gilson P. Dardare J, et al. Among authors: gilson p. Front Oncol. 2022 Dec 8;12:1052163. doi: 10.3389/fonc.2022.1052163. eCollection 2022. Front Oncol. 2022. PMID: 36568213 Free PMC article.

8

Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers.

Gilson P, Pouget C, Belmonte R, Fadil S, Demange J, Rouyer M, Lacour J, Betz M, Dardare J, Witz A, Merlin JL, Harlé A. Gilson P, et al. Sci Rep. 2023 Aug 9;13(1):12909. doi: 10.1038/s41598-023-39749-4. Sci Rep. 2023. PMID: 37558711 Free PMC article.

9

CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines.

Witz A, Dardare J, Francois A, Husson M, Rouyer M, Demange J, Merlin JL, Gilson P, Harlé A. Witz A, et al. Among authors: gilson p. Sci Rep. 2023 Oct 31;13(1):18741. doi: 10.1038/s41598-023-45964-w. Sci Rep. 2023. PMID: 37907567 Free PMC article.

10

ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?

Betz M, Massard V, Gilson P, Witz A, Dardare J, Harlé A, Merlin JL. Betz M, et al. Among authors: gilson p. Cancers (Basel). 2023 Oct 27;15(21):5169. doi: 10.3390/cancers15215169. Cancers (Basel). 2023. PMID: 37958343 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters